Open this publication in new window or tab >>Show others...
2026 (English)In: Chemical Research in Toxicology, ISSN 0893-228X, E-ISSN 1520-5010Article in journal (Refereed) Epub ahead of print
Abstract [en]
Metal additive manufacturing (AM) relies on alloy feedstock powders that may come into contact with the workers' skin during handling, yet skin-relevant data on metal release and biological reactivity remain limited. Here, we assessed the cutaneous bioactivity of the fine particle fraction of four gas-atomized Fe-based AM powders (316L stainless steel, Fe-powder A, and tooling steels B and C). Powders were sieved to <10 mu m and characterized by scanning electron microscopy and X-ray photoelectron spectroscopy before and after incubation in artificial sweat (ASW). Metal biodissolution was quantified in ASW and keratinocyte culture medium using atomic absorption spectrophotometry. Cellular responses were evaluated in HaCaT keratinocytes using Cell Painting-based phenomics and multiplex cytokine/chemokine profiling and in an ex vivo full-thickness human skin explant model, including superficial barrier disruption, IL-8/CXCL8 quantification, and histological assessment. ASW exposure induced marked shifts in the outermost surface composition across powders, indicating sweat-driven surface transformation. Biodissolution was low and medium-dependent, with Fe dominating the release in ASW, and with an overall metal release remaining limited in cell culture medium. In HaCaT cells, MCP-1/CCL2, IL-6, and IL-8/CXCL8 were quantifiable but showed no significant changes following powder exposure. Cell Painting revealed subtle, shared phenotypic signatures, primarily involving mitochondrial-associated features, without evidence of broad cellular stress. In the ex vivo skin model, AM powders did not increase IL-8/CXCL8 secretion, the particles remained localized to the skin surface without detectable penetration, and coexposure with Staphylococcus epidermidis did not enhance bacterial colonization or induce inflammation. To the best of our knowledge, this is the first study that applies a human skin explant model to evaluate dermal responses to metal AM powders. Overall, the tested AM powders showed low short-term cutaneous reactivity under skin-relevant conditions, providing human-relevant evidence to inform occupational risk assessment in AM environments.
Place, publisher, year, edition, pages
American Chemical Society (ACS), 2026
National Category
Respiratory Medicine and Allergy
Identifiers
urn:nbn:se:oru:diva-128721 (URN)10.1021/acs.chemrestox.6c00100 (DOI)001755716100001 ()42070096 (PubMedID)
Funder
Vinnova, 2021−03968Knowledge Foundation, 20160019Knowledge Foundation, 20190107Knowledge Foundation, 20220122Knowledge Foundation, 20230020Novo Nordisk Foundation, NNF22OC0077593Swedish Research Council, VR-M2024−02418Karolinska Institute, 2−1608/2024
Note
This work was supported by the Vinnova, the Swedish Agency for Innovation Systems, [Grant No. 2021−03968], and the Swedish Knowledge Foundation [Grant Nos. 20160019, 20190107, 20220122, and 20230020]. Other supporting funding includes Novo Nordisk Foundation (NNF22OC0077593), Swedish Research Council (VR-M2024−02418), and Karolinska Institutet (2−1608/2024). We acknowledge scientific support from the Exploring Inflammation in Health and Disease (X-HiDE) Consortium, which is a strategic research profile at Örebro University funded by the Knowledge Foundation [Grant No. 20200017].
2026-05-112026-05-112026-05-11Bibliographically approved